Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-01-02 @ 12:03 AM
Study NCT ID:
NCT04498832
Status:
COMPLETED
Last Update Posted:
2025-09-23
First Post:
2020-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and Older
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-21
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-31
First Submit QC Date:
None
Study First Post Date:
2020-08-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-01-11
Results First Submit QC Date:
None
Results First Post Date:
2022-02-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-23
Last Update Post Date Type:
ESTIMATED